Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What is the Anticipated CAGR of the Needle-Free Drug Delivery Devices Market, and What Factors Will Drive It?
The market size for needle-free drug delivery devices has seen rapid expansion in the previous few years. It is projected to escalate from a valuation of $16.7 billion in 2024 to approximately $18.54 billion in 2025, with a compound annual growth rate (CAGR) of 11.0%. Factors contributing to the growth during the historic period include heightened occurrence of chronic illnesses, a growing desire for pain-free methods of drug delivery, a rise in the elderly population, focus on compliance and safety of patients, regulatory endorsement for needle-free technologies, and expanded pharmaceutical industry.
Anticipated to experience significant expansion in the upcoming years, the needle-free drug delivery devices market is projected to increase to a value of $27.68 billion in 2029, with a 10.5% compound annual growth rate (CAGR). The anticipated growth is credited to factors such as the escalating demand for pain-free drug administration, the growing focus on patient-centric medical solutions, and the increasing applications in the pediatric and elderly populations. Additional contributing factors include the rising incidence of chronic conditions requiring regular injections, technological advancements improving device efficiency, expanding access to healthcare in emerging economies, and heightened investment in innovative delivery system research and development. The forecast period is expected to see notable trends such as a surge in the adoption of wearable and connected devices, the development of new microfluidic technologies, increased attention to pediatric-friendly needle-free solutions, the incorporation of artificial intelligence and machine learning, and broader applications in home healthcare environments.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15615&type=smp
What are the Fundamental Drivers and Innovations Shaping the Needle-Free Drug Delivery Devices Market?
The escalating occurrence of diabetes is anticipated to boost the needle-free drug delivery device market’s development in the future. Diabetes is a chronic health issue characterized by elevated blood sugar levels caused by either the inadequate production of insulin or the ineffective use of insulin by the body. Factors escalating the disease include inactive lifestyles, poor eating habits, genetics, urbanization, aging demographics, and lack of healthcare accessibility, coupled with global spikes in obesity. Needle-free drug delivery devices offer a replacement for traditional insulin injections for diabetes management. These devices employ techniques such as jet injectors or transdermal patches, which facilitate painless insulin delivery through the skin and minimize injection-associated discomfort and anxiety, improving patient comfort. As an example, in June 2024, the National Health Service, a UK government department, revealed that 549,000 additional individuals in England were identified as being at risk of type 2 diabetes in 2023. Consequently, the number of non-diabetic hyperglycemia, or prediabetes patients registered with a GP, rose to 3,615,330. This represents a notable increase when compared to the 3,065,825 recorded in 2022, accounting for nearly a 20% rise. Therefore, the escalating occurrence of diabetes is instigating the growth of the needle-free drug delivery device market.
How Is the Needle-Free Drug Delivery Devices Market Segmented?
The needle-free drug delivery devicesmarket covered in this report is segmented –
1) By Device Type: Inhalers; Jet Injectors; Novel Needles; Transdermal Patches; Other Device Types
2) By Application: Pain Management; Vaccine Delivery; Pediatric Injections; Insulin Delivery; Other Applications
3) By End-User: Hospitals And Clinics; Home Healthcare
Subsegments:
1) By Inhalers: Dry Powder Inhalers (Dpi); Metered Dose Inhalers (Mdi); Nebulizers
2) By Jet Injectors: High-Pressure Jet Injectors; Spring-Powered Jet Injectors; Battery-Operated Jet Injectors
3) By Novel Needles: Micro-Needle Arrays; Nano-Needle Arrays
4) By Transdermal Patches: Microneedle Patches; Conventional Patches ( Nicotine, Hormonal, Pain Relief)
5) By Other Device Types: Oral Drug Delivery Devices; Implantable Drug Delivery Systems; Sublingual Drug Delivery Devices
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=15615&type=smp
Which Regions Are Driving the Next Phase of the Needle-Free Drug Delivery Devices Market Growth?
North America was the largest region in the needle-free drug delivery devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the needle-free drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Key Trends Are Shaping the Future of the Needle-Free Drug Delivery Devices Market?
As part of their strategy to deliver superior service, prominent firms in the needle-free drug delivery device market are concentrating on innovative solutions like dual chamber inhalers to enhance treatment efficiency and convenience. Dual-chamber inhalers, which have two separate compartments for different medications, simplify treatment by allowing multiple drugs to be combined in one device, thereby increasing ease of administration for patients and healthcare providers. In this regard, Berry Global, an American plastic manufacturing firm, launched the BerryHaler in April 2024. This state-of-the-art dry powder inhaler (DPI) was created to transform patient-oriented healthcare solutions. Its distinctive design hails a dosage counter for accurately administering medicine, and its entirely plastic make-up, free of metal components, is extremely well-suited for intricate inhalation treatments. The BerryHaler simplifies dosage and efficiently combines multiple medicines. This dual-chamber inhaler also features a bi-directional mouthpiece cover for user comfort and sanitation, and supplies audible cues to guarantee correct usage. The integrated dose counter plays a crucial role in precisely tracking medication usage and avoiding dosage mistakes.
View the full report here:
How Is the Needle-Free Drug Delivery Devices Market Defined and What Are Its Core Parameters?
Needle-free drug delivery devices refer to medical tools designed to administer medication without traditional needles. They offer an alternative means of delivering drugs, vaccines, or therapeutic agents into the body through the skin or mucosal membranes. These devices aim to reduce patient discomfort and the risk of needle-related injuries.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15615
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model